Insulet Corporation

Insulet Corporation

About

Company Stage

IPO

Employees

1,001-5,000

Industries

Biotechnology, Healthcare

Total Funding

$134.6M

Headquarters

Acton, Massachusetts

Founded

2000


Simplify Jobs

Simplify's Take

What believers are saying

  • Omnipod 5's expansion in Europe boosts Insulet's international market presence.
  • New manufacturing facility in Malaysia supports increased production capacity and job creation.
  • Growing global insulin pump market offers significant revenue opportunities for Insulet.

What critics are saying

  • Emerging competitors like Tandem Diabetes Care threaten Insulet's market share.
  • Geopolitical tensions in Malaysia could disrupt Insulet's supply chain.
  • Technical challenges with sensor integration may delay Omnipod 5 product rollouts.

What makes Insulet Corporation unique

  • Insulet's Omnipod 5 offers tubeless insulin delivery, a unique market feature.
  • Integration with Dexcom G7 and FreeStyle Libre 2 Plus enhances Omnipod 5's functionality.
  • Insulet's proprietary technology is protected by a recent $452 million trade secret victory.

Help us improve and share your feedback! Did you find this helpful?


Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%

Benefits

Remote Work Options

Recently Posted Jobs

Sign up to get curated job recommendations

Insulet Corporation is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Insulet Corporation's jobs every 8 hours, so check again soon! Browse all jobs →